Expert Opinion on Drug Safety (EODS)

Expert Opinion on Drug Safety [ISSN 1474-0338]; [e- ISSN 1744-764X] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles on all aspects of drug safety, as well as original papers on the clinical implications of drug treatment safety issues. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. Expert Opinion on Drug Safety aims to address the needs of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in monitoring drug safety. The journal welcomes: Reviews covering occurrence, management and prevention of drug-associated adverse events Reviews covering risk-benefit analyses of individual drugs and drug classes Reviews covering safety in 'at-risk' patient populations Reviews covering comparative tolerability studies Reviews covering pharmacovigilance and pharmacoepidemiological studies Drug safety evaluations reviewing the safety data on a specific drug Original research papers reporting the results of post-marketing surveillance and other safety studies looking at specific drugs, populations and outcomes Original research papers on methods for the detection and evaluation of drug-associated adverse events

Expert Opinion on Drug Safety (EODS) is :-

• International, Peer-Reviewed, Open Access, Refereed, occurrence, management, pharmacoepidemiological studies, pharmacovigilance, the safety data, specific drugs, risk-benefit analyses , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1474-0338, E-ISSN: 1744-764X, Established: 2002, Impact Factor: 3.0
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE